PoliticsAPC’s Rally Rollout Contrasts With Opposition’s Slower Campaign CalendarBy Julian ArdentNov 3, 2026, 3:50 PM UTC
HealthMabwell Reports 30% Response Rate for 9MW2821 in ADC-Pretreated TNBCBy Naomi CalderOct 19, 2026, 2:41 AM UTC
BusinessMersana Therapeutics to Host Conference Call Announcing First Quarter 2018 Financial Results and Business UpdatesBy Nasdaq OMXMay 7, 2018, 8:01 PM UTC
BusinessMersana Therapeutics to Present at the Deutsche Bank 43rd Annual Health Care ConferenceBy Nasdaq OMXMay 1, 2018, 8:01 PM UTC
BusinessMersana Therapeutics Presents Preclinical Data Further Demonstrating Differentiating Aspects of Its ADC Platform Technology at AACR 2018By Nasdaq OMXApr 17, 2018, 5:01 PM UTC
BusinessMersana Therapeutics Announces Poster Presentations Demonstrating Differentiating Aspects of ADC Platform Technology at the American Association for Cancer Research Annual Meeting 2018By Nasdaq OMXApr 9, 2018, 12:01 PM UTC
BusinessMersana Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Business UpdatesBy Nasdaq OMXMar 28, 2018, 11:30 AM UTC
BusinessMersana Strengthens Board of Directors Leadership with Appointment of Willard H. Dere, M.D., Professor at the University of Utah and Retired Chief Medical Officer of AmgenBy Nasdaq OMXMar 19, 2018, 12:01 PM UTC
